within Pharmacolibrary.Drugs.ATC.S;

model S01EC05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.95,
    Cl             = 0.0023333333333333335,
    adminDuration  = 600,
    adminMass      = 0.05,
    adminCount     = 1,
    Vd             = 0.0002,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0010833333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Methazolamide is a carbonic anhydrase inhibitor used primarily in the treatment of glaucoma to reduce intraocular pressure. It is approved and in clinical use today for the management of ocular hypertension and some forms of epilepsy.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following single oral administration.</p><h4>References</h4><ol><li><p>Iyer, GR, &amp; Taft, DR (1998). Determination of methazolamide concentrations in human biological fluids using high performance liquid chromatography. <i>Journal of pharmaceutical and biomedical analysis</i> 16(6) 1021–1027. DOI:<a href=&quot;https://doi.org/10.1016/s0731-7085(97)00061-7&quot;>10.1016/s0731-7085(97)00061-7</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9547705/&quot;>https://pubmed.ncbi.nlm.nih.gov/9547705</a></p></li><li><p>Taft, DR, et al., &amp; Schwenk, MH (1998). Blood disposition and urinary excretion kinetics of methazolamide following oral administration to human subjects. <i>Biopharmaceutics &amp; drug disposition</i> 19(6) 373–380. DOI:<a href=&quot;https://doi.org/10.1002/(sici)1099-081x(199809)19:6&lt;373::aid-bdd113&gt;3.0.co;2-t&quot;>10.1002/(sici)1099-081x(199809)19:6&lt;373::aid-bdd113&gt;3.0.co;2-t</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9737818/&quot;>https://pubmed.ncbi.nlm.nih.gov/9737818</a></p></li><li><p>Kobayashi, M, &amp; Naito, K (2000). [Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent]. <i>Nihon yakurigaku zasshi. Folia pharmacologica Japonica</i> 115(6) 323–328. DOI:<a href=&quot;https://doi.org/10.1254/fpj.115.323&quot;>10.1254/fpj.115.323</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10948564/&quot;>https://pubmed.ncbi.nlm.nih.gov/10948564</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01EC05;
